Application of a self-developed femoral artery compression hemostasis device in proximal femoral nail anti-rotation surgery for intertrochanteric fractures: a case report - Report - MDSpire
Advertisement
Application of a self-developed femoral artery compression hemostasis device in proximal femoral nail anti-rotation surgery for intertrochanteric fractures: a case report
Clinical Report: Utilization of a Novel Hemostasis Device for Femoral Artery Compression
Overview
This case study demonstrates the effective use of a novel femoral artery hemostasis device during proximal femoral nail anti-rotation surgery for an intertrochanteric fracture. The device significantly reduced intraoperative blood loss while maintaining a favorable safety profile.
Background
Intertrochanteric fractures are common in the elderly and often require surgical intervention to prevent complications associated with prolonged immobility. Traditional hemostatic methods have limitations, particularly in hip surgeries where conventional tourniquets cannot be applied. This case highlights the need for innovative hemostatic solutions to manage blood loss effectively during such procedures.
Data Highlights
Parameter
Value
Estimated intraoperative blood loss
50 mL
Total perioperative blood loss
433 mL
Hidden blood loss
383 mL
Postoperative hematocrit (Day 2)
0.358
Key Findings
The novel hemostasis device effectively controlled regional blood flow during surgery.
Intraoperative visible blood loss was estimated at 50 mL.
Total perioperative blood loss calculated at 433 mL, with significant hidden blood loss.
No postoperative complications were reported, including limb ischemia or deep vein thrombosis.
The patient demonstrated satisfactory recovery with stable internal fixation at follow-up.
Clinical Implications
The use of a femoral artery compression device may provide a safe and effective alternative for managing intraoperative blood loss in hip fracture surgeries, particularly for patients contraindicated for pharmacological hemostatic agents. Further studies are warranted to validate these findings across larger populations.
Conclusion
This case study supports the potential of a novel hemostatic device in reducing blood loss during hip fracture surgeries, highlighting the need for continued exploration of non-invasive hemostatic strategies.
